Diabetes Care 2010, 33, 12551261
Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, et al
Patients who maintain structured eating patterns, prioritize protein, and minimize highly processed, energy-dense foods tend to do better, although the effect is often modest without ongoing pharmacotherapy
While medications like Semaglutide target only the GLP-1 receptor and Tirzepatide activates both GIP and GLP-1 receptors, Retatrutide adds glucagon receptor activation to create a more comprehensive metabolic intervention
Product Facts Supplement Facts Serving Size 1 Capsule Servings Per Container 90 Daily Value not established
Product Specifications Research Overview BPC-157, also written as BPC 157 or BPC157, is a synthetic pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), molecular formula CHNO and molecular weight 1419.53 g/mol